Pharmacological optimization of tissue perfusion

British Journal of Anaesthesia

Volumn 103, Issue 1, 2009, Pages 82-88

  Mongardon, N ^a   Dyson, A ^a   Singer, M ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Arterial pressure, drug effects; Cardiovascular system, effects; Heart, cardiac output; Oxygen, therapy; Pharmacology, agonists adrenergic

Indexed keywords

ADRENALIN; ADRENERGIC RECEPTOR STIMULATING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CATECHOLAMINE DERIVATIVE; DOBUTAMINE; DOPAMINE; HYPERTENSIVE FACTOR; INOTROPIC AGENT; LEVOSIMENDAN; N(G) METHYLARGININE; NITRIC ACID DERIVATIVE; NORADRENALIN; PHOSPHODIESTERASE INHIBITOR; PLACEBO; POLYOXYETHYLENE; TERLIPRESSIN; VASOACTIVE AGENT; VASOPRESSIN; CARDIOTONIC AGENT; VASOCONSTRICTOR AGENT;

CARDIOGENIC SHOCK; CENTRAL VENOUS PRESSURE; CIRCULATION; FLUID RESUSCITATION; HEART ARREST; HEART ARRHYTHMIA; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HEART OUTPUT; HEMORRHAGIC SHOCK; HOSPITAL INFECTION; HUMAN; HYPERGLYCEMIA; HYPOTENSION; ILEUS; INSULIN RESISTANCE; ISCHEMIA; LIPOLYSIS; LIVER DYSFUNCTION; MALABSORPTION; MEAN ARTERIAL PRESSURE; OXYGEN CONSUMPTION; OXYGEN SATURATION; OXYGEN SUPPLY; PRIORITY JOURNAL; PULSE PRESSURE; REVIEW; SEPTIC SHOCK; SIDE EFFECT; STRESS ULCER; TACHYCARDIA; THROMBOSIS; TISSUE PERFUSION; VASOCONSTRICTION; VITAL SIGN; BLOOD PRESSURE; CARDIOVASCULAR SYSTEM; DRUG EFFECT; METHODOLOGY; MONITORING;

BLOOD PRESSURE; CARDIAC OUTPUT; CARDIOTONIC AGENTS; CARDIOVASCULAR SYSTEM; HUMANS; MONITORING, PHYSIOLOGIC; OXYGEN CONSUMPTION; VASOCONSTRICTOR AGENTS;

EID: 67650713728     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/aep135     Document Type: Review

References (119)

1. Abraham E, Singer M. Mechanisms of sepsis-induced organ dysfunction. Crit Care Med 2007; 35: 2408-16
2. Abraham WT, Adams KF, Fonarow GC, et al. In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE). J Am Coll Cardiol 2005; 46: 57-64
3. Annane D, Vignon P, Renault A, et al. Norepinephrine plus dobu-tamine versus epinephrine alone for management of septic shock: a randomised trial. Lancet 2007; 370: 676-84
4. Bailey AR, Burchett KR. Effect of low-dose dopamine on serum concentrations of prolactin in critically ill patients. Br J Anaesth 1997; 78: 97-9
5. Barraud D, Faivre V, Damy T, et al. Levosimendan restores both systolic and diastolic cardiac performance in lipopolysaccharide-treated rabbits: comparison with dobutamine and milrinone. Crit Care Med 2007; 35: 1376-82
6. Barrett LK, Singer M, Clapp LH. Vasopressin: mechanisms of action on the vasculature in health and in septic shock. Crit Care Med 2007; 35: 33-40
7. Belikova I, Lukaszewicz AC, Faivre V, Damoisel C, Singer M, Payen D. Oxygen consumption of human peripheral blood mononuclear cells in severe human sepsis. Crit Care Med 2007; 35: 2702-8
8. Bersten AD, Holt AW. Vasoactive drugs and the importance of renal perfusion pressure. New Horiz 1995; 3: 650-61
9. Binanay C, Califf RM, Hasselblad V, et al. Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: the ESCAPE trial. J Am Med Assoc 2005; 294: 1625-33
10. Bourgoin A, Leone M, Delmas A, Garnier F, Albanèse J, Martin C. Increasing mean arterial pressure in patients with septic shock: effects on oxygen variables and renal function. Crit Care Med 2005; 33: 780-6
11. Bundgaard-Nielsen M, Holte K, Secher NH, Kehlet H. Monitoring of peri-operative fluid administration by individualized goal-directed therapy. Acta Anaesthesiol Scand 2007; 51: 331-40
12. Chappell D, Jacob M, Hofmann-Kiefer K, Conzen P, Rehm M. A rational approach to perioperative fluid management. Anesthesiology 2008; 109: 723-40
13. Chen JM, Cullinane S, Spanier TB, et al. Vasopressin deficiency and pressor hypersensitivity in hemodynamically unstable organ donors. Circulation 1999; 100: 11244-6
14. Cohn JN, Goldstein SO, Greenberg BH, et al. A dose-dependent increase in mortality with vesnarinone among patients with severe heart failure. Vesnarinone Trial Investigators. N Engl J Med 1998; 339: 1810-6
15. Cuffe MS, Califf RM, Adams KF, Jr, et al., Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF) Investigators. Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial. J Am Med Assoc 2002; 287: 1541-7
16. De Backer D, Heenen S, Piagnerelli M, Koch M, Vincent JL. Pulse pressure variations to predict fluid responsiveness: influence of tidal volume. Intensive Care Med 2005; 31: 517-23
17. De Hert SG, Lorsomradee S, Cromheecke S, Van der Linden PJ. The effects of levosimendan in cardiac surgery patients with poor left ventricular function. Anesth Analg 2007; 104: 766-73
18. Deitch EA, Dayal SD. Intensive care unit management of the trauma patient. Crit Care Med 2006; 34: 2294-301
19. Dellinger RP, Levy MM, Carlet JM, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock. Crit Care Med 2008; 36: 296-327
20. Den Uil CA, Klijn E, Lagrand WK, et al. The microcirculation in health and critical disease. Prog Cardiovasc Dis 2008; 51: 161-70
21. Desjars P, Pinaud M, Bugnon D, Tasseau F. Norepinephrine therapy has no deleterious renal effects in human septic shock. Crit Care Med 1989; 17: 426-9
22. Desjars P, Pinaud M, Potel G, Tasseau F, Touze MD. A reappraisal of norepinephrine therapy in human septic shock. Crit Care Med 1987; 15: 134-7
23. Dickerson RN, Roth-Yousey L. Medication effects on metabolic rate: a systematic review (part 1). J Am Diet Assoc 2005; 105: 835-43
24. Dickerson RN, Roth-Yousey L. Medication effects on metabolic rate: a systematic review (part 2). J Am Diet Assoc 2005; 105: 1002-9
25. Dubin A, Murias G, Sottile JP, et al. Effects of levosimendan and dobutamine in experimental acute endotoxemia: a preliminary controlled study. Intensive Care Med 2007; 33: 485-94
26. Dünser MW, Mayr AJ, Ulmer H, et al. Arginine vasopressin in advanced vasodilatory shock: a prospective, randomized, controlled study. Circulation 2003; 107: 2313-9
27. Dünser MW, Takala J, Ulmer H, et al. Arterial blood pressure during early sepsis and outcome. Intensive Care Med 2009; February 3 (Epub ahead of print)
28. Efrati O, Modan-Moses D, Vardi A, Matok I, Brazilay Z, Paret G. Intravenous arginine vasopressin in critically ill children: is it beneficial? Shock 2004; 22: 213-7
29. Ensinger H, Geisser W, Brinkmann A, et al. Metabolic effects of norepinephrine and dobutamine in healthy volunteers. Shock 2002; 18: 495-500
30. Ensinger H, Weichel T, Lindner KH, Grünert A, Ahnefeld FW. Effects of norepinephrine, epinephrine, and dopamine infusions on oxygen consumption in volunteers. Crit Care Med 1993; 21: 1502-8
31. Fellahi JL, Parienti JJ, Hanouz JL, Plaud B, Riou B, Ouattara A. Perioperative use of dobutamine in cardiac surgery and adverse cardiac outcome: propensity-adjusted analyses. Anesthesiology 2008; 108: 979-87
32. Finfer S, Bellomo R, Boyce N, et al. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med 2004; 350: 2247-56
33. Follath F, Cleland JG, Just H, et al. Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial. Lancet 2002; 360: 196-202
34. Freestone PP, Haigh RD, Williams PH, Lyte M. Involvement of enterobactin in norepinephrine-mediated iron supply from transferrin to enterohaemorrhagic Escherichia coli. FEMS Microbiol Lett 2003; 222: 39-43
35. Freestone PP, Lyte M, Neal CP, Maggs AF, Haigh RD, Williams PH. The mammalian neuroendocrine hormone norepinephrine supplies iron for bacterial growth in the presence of transferrin or lactoferrin. J Bacteriol 2000; 182: 6091-8
36. Freestone PP, Williams PH, Haigh RD, Maggs AF, Neal CP, Lyte M. Growth stimulation of intestinal commensal Escherichia coli by catecholamines: a possible contributory factor in trauma-induced sepsis. Shock 2002; 18: 465-70
37. Fukuoka T, Nishimura M, Imanaka H, Taenaka N, Yoshiya I, Takezawa J. Effects of norepinephrine on renal function in septic patients with normal and elevated serum lactate levels. Crit Care Med 1989; 17: 1104-7
38. 2 Collaborative Group. N Engl J Med 1995; 333: 1025-32
39. Grocott MP, Mythen MG, Gan TJ. Perioperative fluid management and clinical outcomes in adults. Anesth Analg 2005; 100: 1093-106
40. Harvey S, Harrison DA, Singer M, et al., PAC-Man study collaboration. Assessment of the clinical effectiveness of pulmonary artery catheters in management of patients in intensive care (PAC-Man): a randomised controlled trial. Lancet 2005; 366: 472-7
41. Harvey SE, Welch CA, Harrison DA, Rowan KM, Singer M. Post hoc insights from PAC-Man - the U.K. pulmonary artery catheter trial. Crit Care Med 2008; 36: 1714-21
42. Hayes MA, Timmins AC, Yau EH, Palazzo M, Hinds CJ, Watson D. Elevation of systemic oxygen delivery in the treatment of critically ill patients. N Engl J Med 1994; 330: 1717-22
43. Hayes MA, Timmins AC, Yau EH, Palazzo M, Watson D, Hinds CJ. Oxygen transport patterns in patients with sepsis syndrome or septic shock: influence of treatment and relationship to outcome. Crit Care Med 1997; 5: 926-36
44. Herget-Rosenthal S, Marggraf G, Hüsing J, et al. Early detection of acute renal failure by serum cystatin C. Kidney Int 2004; 66: 1115-22
45. Hollenberg SM. Vasopressor support in septic shock. Chest 2007; 132: 1678-87
46. Holmes CL, Walley KR, Chittock DR, Lehman T, Russell JA. The effects of vasopressin on hemodynamics and renal function in severe septic shock: a case series. Intensive Care Med 2001; 27: 1416-21
47. Holte K, Foss NB, Andersen J, et al. Liberal or restrictive fluid administration in fast-track colonic surgery: a randomized, double-blind study. Br J Anaesth 2007; 99: 500-8
48. Joshi GP. Intraoperative fluid restriction improves outcome after major elective gastrointestinal surgery. Anesth Analg 2005; 101: 601-5
49. Kinasewitz GT, Privalle CT, Imm A, et al. Multicenter, randomized, placebo-controlled study of the nitric oxide scavenger pyridoxalated hemoglobin polyoxyethylene in distributive shock. Crit Care Med 2008; 36: 1999-2007
50. Kirchheim HR, Ehmke H, Hackenthal E, Löwe W, Persson P. Autoregulation of renal blood flow, glomerular filtration rate and renin release in conscious dogs. Pflugers Arch 1987; 410: 441-9
51. Landry DW, Levin HR, Gallant EM, et al. Vasopressin deficiency contributes to the vasodilation of septic shock. Circulation 1997; 95: 1122-5
52. LeDoux D, Astiz ME, Carpati CM, Rackow EC. Effects of per-fusion pressure on tissue perfusion in septic shock. Crit Care Med 2000; 28: 2729-32
53. Leone M, Martin C. Vasopressor use in septic shock: an update. Curr Opin Anaesthesiol 2008; 21: 141-7
54. Levy B, Bollaert PE, Charpentier C, et al. Comparison of nor-epinephrine and dobutamine to epinephrine for hemodynamics, lactate metabolism, and gastric tonometric variables in septic shock: a prospective, randomized study. Intensive Care Med 1997; 23: 282-7
55. + ATPPase activity and raised lactate concentrations in septic shock: a prospective study. Lancet 2005; 365: 871-5
56. Lobo SM, Salgado PF, Castillo VG, et al. Effects of maximizing oxygen delivery on morbidity and mortality in high-risk surgical patients. Crit Care Med 2000; 28: 3396-404
57. López A, Lorente JA, Steingrub J, et al. Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: effect on survival in patients with septic shock. Crit Care Med 2004; 32: 21-30
58. Lünemann JD, Buttgereit F, Tripmacher R, Baerwald CG, Burmester GR, Krause A. Norepinephrine inhibits energy metabolism of human peripheral blood mononuclear cells via adrenergic receptors. Biosci Rep 2001; 21: 627-35
59. Lyte M, Freestone PP, Neal CP, et al. Stimulation of Staphylococcus epidermidis growth and biofilm formation by catecholamine inotropes. Lancet 2003; 361: 130-5
60. Mebazaa A, Nieminen MS, Filippatos GS, et al. Levosimendan vs. dobutamine: outcomes for acute heart failure patients on β-blockers in SURVIVE. Eur J Heart Fail 2009; 11: 304-11
61. Mebazaa A, Nieminen MS, Packer M, et al. Levosimendan vs dobutamine for patients with acute decompensated heart failure: the SURVIVE Randomized Trial. J Am Med Assoc 2007; 297: 1883-91
62. Meier-Hellmann A, Reinhart K, Bredle DL, Specht M, Spies CD, Hannemann L. Epinephrine impairs splanchnic perfusion in septic shock. Crit Care Med 1997; 25: 399-404
63. Merry A. What blood pressure is appropriate for cardiopulmon-ary bypass and how to get it. J Extra Corpor Technol 2006; 38: 69-71
64. Morales DL, Gregg D, Helman DN, et al. Arginine vasopressin in the treatment of 50 patients with postcardiotomy vasodila-tory shock. Ann Thorac Surg 2000; 69: 102-6
65. Müllner M, Urbanek B, Havel C, Losert H, Waechter F, Gamper G. Vasopressors for shock. Cochrane Database Syst Rev 2004; 3: CD003709
66. Myburgh JA, Higgins A, Jovanovska A, Lipman J, Ramakrishnan N, Santamaria J, CAT Study investigators. A comparison of epinephrine and norepinephrine in critically ill patients. Intensive Care Med 2008; 34: 2226-34
67. National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials NetworkWheeler AP, Bernard GR, et al. Pulmonary-artery versus central venous catheter to guide treatment of acute lung injury. N Engl J Med 2006; 354: 2213-24
68. Neal CP, Freestone PP, Maggs AF, Haigh RD, Williams PH, Lyte M. Catecholamine inotropes as growth factors for Staphylococcus epidermidis and other coagulase-negative staphylococci. FEMS Microbiol Lett 2001; 194: 163-9
69. Neri M, Cerretani D, Fiaschi AI, et al. Correlation between cardiac oxidative stress and myocardial pathology due to acute and chronic norepinephrine administration in rats. J Cell Mol Med 2007; 11: 156-70
70. Nickolas TL, O'Rourke MJ, Yang J, et al. Sensitivity and specificity of a single emergency department measurement of urinary neutrophil gelatinase-associated lipocalin for diagnosing acute kidney injury. Ann Intern Med 2008; 148: 810-9
71. Nieminen MS, Böhm M, Cowie MR, et al. Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology. Eur Heart J 2005; 26: 384-416
72. Nouira S, Elatrous S, Dimassi S, et al. Effects of norepinephrine on static and dynamic preload indicators in experimental hemorrhagic shock. Crit Care Med 2005; 33: 2339-43
73. Novotny NM, Lahm T, Markel TA, et al. Beta-blockers in sepsis: reexamining the evidence. Shock 2009; 31: 113-9
74. Oberbeck R. Catecholamines: physiological immunomo-dulators during health and illness. Curr Med Chem 2006; 13: 1979-89
75. Oberbeck R, Schmitz D, Schüler M, Wilsenack K, Schedlowski M, Exton M. Dopexamine and cellular immune functions during systemic inflammation. Immunobiology 2004; 208: 429-38
76. Oberbeck R, Schmitz D, Wilsenack K, et al. Dopamine affects cellular immune functions during polymicrobial sepsis. Intensive Care Med 2006; 32: 731-9
77. O'Brien A, Clapp L, Singer M. Terlipressin for norepinephrine-resistant septic shock. Lancet 2002; 359: 1209-10
78. Onorati F, Santarpino G, Presta P, et al. Pulsatile perfusion with intra-aortic balloon pumping ameliorates whole body response to cardiopulmonary bypass in the elderly. Crit Care Med 2009; 37: 902-11
79. Parikh CR, Jani A, Melnikov VY, Faubel S, Edelstein CL. Urinary interleukin-18 is a marker of human acute tubular necrosis. Am J Kidney Dis 2004; 43: 405-14
80. Patel BM, Chittock DR, Russell JA, Walley KR. Beneficial effects of short-term vasopressin infusion during severe septic shock. Anesthesiology 2002; 96: 576-82
81. Perel P, Roberts I. Colloids versus crystalloids for fluid resuscitation in critically ill patients. Cochrane Database Syst Rev 2007; 17: CD000567
82. Pinsky MR, Teboul JL. Assessment of indices of preload and volume responsiveness. Curr Opin Crit Care 2005; 11: 235-9
83. Raja SG, Rayen BS. Levosimendan in cardiac surgery: current best available evidence. Ann Thorac Surg 2006; 81: 1536-46
84. Redl-Wenzl EM, Armbruster C, Edelmann G, et al. The effects of norepinephrine on hemodynamics and renal function in severe septic shock states. Intensive Care Med 1993; 19: 151-4
85. Rivers E, Nguyen B, Havstad S, et al. Early Goal-Directed Therapy Collaborative Group. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001; 345: 1368-77
86. Rivers EP, Ander DS, Powell D. Central venous oxygen saturation monitoring in the critically ill patient. Curr Opin Crit Care 2001; 7: 204-11
87. Rizoli SB. Crystalloids and colloids in trauma resuscitation: a brief overview of the current debate. J Trauma 2003; 54: S82-8
88. Rudiger A, Singer M. Mechanisms of sepsis-induced cardiac dysfunction. Crit Care Med 2007; 35: 1599-608
89. Rump AF, Rösen R, Klaus W. Cardioprotection by superoxide dismutase: a catecholamine-dependent process? Anesth Analg 1993; 76: 239-46
90. Russell JA, Walley KR, Gordon AC, et al. Interaction of vasopressin infusion, corticosteroid treatment, and mortality of septic shock. Crit Care Med 2009; 37: 811-8
91. Russell JA, Walley KR, Singer J, et al. Vasopressin versus norepi-nephrine infusion in patients with septic shock. N Engl J Med 2008; 358: 877-87
92. Sandham JD, Hull RD, Brant RF, et al. A randomized, controlled trial of the use of pulmonary-artery catheters in high-risk surgical patients. N Engl J Med 2003; 348: 5-14
93. Schmittinger CA, Dünser MW, Haller M, et al. Combined milri-none and enteral metoprolol therapy in patients with septic myocardial depression. Crit Care 2008; 12: R99
94. Schortgen F, Girou E, Deye N, Brochard L, CRYCO Study Group. The risk associated with hyperoncotic colloids in patients with shock. Intensive Care Med 2008; 34: 2157-68
95. Shoemaker WC, Appel PL, Waxman K, Schwartz S, Chang P. Clinical trial of survivors' cardiorespiratory patterns as therapeutic goals in critically ill postoperative patients. Crit Care Med 1982; 10: 398-403
96. Singer M. Catecholamine treatment for shock - equally good or bad? Lancet 2007; 370: 636-7
97. Sladen RN, Landry D. Renal blood flow regulation, autoregula-tion, and vasomotor nephropathy. Anesthesiol Clin North Am 2000; 18: 791-807
98. Tamion F, Richard V, Lyoumi S, et al. Gut ischemia and mesen-teric synthesis of inflammatory cytokines after hemorrhagic or endotoxic shock. Am J Physiol 1997; 273: 314-21
99. The National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network, Wheeler AP, Bernard GR, et al. Pulmonary-artery versus central venous catheter to guide treatment of acute lung injury. N Engl J Med 2006; 354: 2213-24
100. Toller WG, Stranz C. Levosimendan, a new inotropic and vasodilator agent. Anesthesiology 2006; 104: 556-69
101. Tote SP, Grounds RM. Performing perioperative optimization of the high-risk surgical patient. Br J Anaesth 2006; 97: 4-11
102. Tritapepe L, De Santis V, Vitale D, et al. Preconditioning effects of levosimendan in coronary artery bypass grafting - a pilot study. Br J Anaesth 2006; 96: 694-700
103. TRIUMPH Investigators Alexander JH, Reynolds HR, et al. Effect of tilarginine acetate in patients with acute myocardial infarction and cardiogenic shock: the TRIUMPH randomized controlled trial. J Am Med Assoc 2007; 297: 1657-66
104. Vallet B, Wiel E, Lebuffe G. Resuscitation from circulatory shock. In: Fink MP, Abraham E, Vincent JL, Kochanek PM, eds. Textbook of Critical Care, 5th Edn. Philadelphia: Elsevier Saunders, 2005; 905-10
105. Van den Berghe G, de Zegher F. Anterior pituitary function during critical illness and dopamine treatment. Crit Care Med 1996; 24: 1580-90
106. Van der Heijden M, Verheij J, van Nieuw Amerongen GP, Groeneveld AB. Crystalloid or colloid fluid loading and pulmonary permeability, edema, and injury in septic and nonseptic critically ill patients with hypovolemia. Crit Care Med 2009; 37: 1275-81
107. Van der Poll T, Coyle SM, Barbosa K, Braxton CC, Lowry SF. Epinephrine inhibits tumor necrosis factor-alpha and potentiates interleukin 10 production during human endotoxemia. J Clin Invest 1996; 97: 713-9
108. Van der Poll T, Jansen J, Endert E, Sauerwein HP, van Deventer SJ. Noradrenaline inhibits lipopolysaccharide-induced tumor necrosis factor and interleukin 6 production in human whole blood. Infect Immun 1994; 62: 2046-50
109. Vanhorebeek I, Langouche L, Van den Berghe G. Tight blood glucose control: what is the evidence? Crit Care Med 2007; 35: S496-502
110. Villa P, Jiménez M, Soriano MC, Manzanares J, Casasnovas P. Serum cystatin C concentration as a marker of acute renal dysfunction in critically ill patients. Crit Care 2005; 9: R139-43
111. Vincent JL. Does central venous oxygen saturation accurately reflect mixed venous oxygen saturation? Nothing is simple, unfortunately. Intensive Care Med 1992; 18: 386-7
112. Vincent JL, De Backer D. Oxygen transport - the oxygen delivery controversy. Intensive Care Med 2004; 30: 1990-6
113. Vo n K änel R, Dimsdale JE. Effects of sympathetic activation by adrenergic infusions on hemostasis in vivo. Eur J Haematol 2000; 65: 357-69
114. Wang P, Tait SM, Chaudry IH. Sustained elevation of norepi-nephrine depresses hepatocellular function. Biochim Biophys Acta 2000; 1535: 36-44
115. Wilson J, Woods I, Fawcett J, et al. Reducing the risk of major elective surgery: randomised controlled trial of preopera-tive optimisation of oxygen delivery. Br Med J 1999; 318: 1099-103
116. Woiciechowsky C, Schöning B, Lanksch WR, Volk HD, Döcke WD. Catecholamine-induced interleukin-10 release: a key mechanism in systemic immunodepression after brain injury. Crit Care 1999; 3: R107-11
117. Yu M, Levy MM, Smith P, Takiguchi SA, Miyasaki A, Myers SA. Effect of maximizing oxygen delivery on morbidity and mortality rates in critically ill patients: a prospective, randomized, controlled study. Crit Care Med 1993; 21: 830-8
118. Zager RA, Johnson AC, Lund S, Hanson SY, Abrass CK. Levosimendan protects against experimental endotoxemic acute renal failure. Am J Physiol Renal Physiol 2006; 290: 1453-62
119. Zanotti Cavazzoni SL, Dellinger RP. Hemodynamic optimization of sepsis-induced tissue hypoperfusion. Crit Care 2006; 10: S2